Daniel Molin

Adjunct senior lecturer at Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy; Research group Daniel Molin

Mobile phone:
+46 70 204 74 18
E-mail:
daniel.molin@igp.uu.se
Visiting address:
Dag Hammarskjölds väg 20
751 85 Uppsala
Postal address:
Rudbecklaboratoriet
751 85 UPPSALA

Download contact information

ORCID:
0009-0005-6662-4865

Short presentation

Chairman of The Swedish Hodgkin Lymphoma Group and the Nordic working group for Hodgkin lymphoma. Previously (2020-2026) chair of The Swedish Lymphoma Group (SLG).

Head of the lymphoma team, Uppsala University hospital.

Group leader in the cancer immunotherapy programme, Department of Immunology, Genetics and Pathology, Uppsala University. Clinical and translational research in lymphoma, especially Hodgkin lymphoma.

Biography

Daniel Molin is an oncology consultant at Uppsala University Hospital, specializing in lymphomas. He earned his medical degree from Uppsala University and completed his residency at Uppsala University Hospital. Dr. Molin is an expert in lymphomas in general, with a special focus on Hodgkin lymphomas, including nodular lymphocyte predominant Hodgkin lymphoma. He is a research group leader at the Department of Immunology, Genetics and Pathology (IGP), Uppsala University, and also the head of the clinical lymphoma group at Uppsala University Hospital.

 He defended his PhD 24 years ago on Hodgkin lymphoma with a focus on the microenvironment in the tumors and an epidemiological evaluation of treatment outcomes. The microenvironment in particular was then largely unexplored territory. In recent years, both the microenvironment and epidemiology have become significant areas of research. His research has since then been based on these areas but has also broadened to include, for example, clinical treatment studies, radiology, radiotherapy, side effects, genetics and proteomics, and has also been extended to include other lymphomas. Some of his current research also has implications for completely different cancers.

 Dr. Molin is chair of the Nordic Hodgkin lymphoma working group and the Swedish Hodgkin Lymphoma Group, and previous (2020-2026) chair of the Swedish Lymphoma Group (SLG). He is also an active member of e.g. the European Hematology Association (EHA) Lymphoma Group, the International Lymphoma Radiation Group (ILROG), the Nordic Lymphoma Group, and the national groups for T-cell lymphoma and Aggressive B-cell lymphomas. 

 With an interest for both research and clinical work, Dr. Molin remain focused on the best possible outcomes for the individual patient. 

Daniel Molin

Publications

Selection of publications

Recent publications

All publications

Articles in journal

Manuscripts (preprints)

FOLLOW UPPSALA UNIVERSITY ON

Uppsala University on Facebook
Uppsala University on Instagram
Uppsala University on Youtube
Uppsala University on Linkedin